ArticleMolecular cancer research : MCR2015

RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Guoyu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.